The principal neutralization epitope of human immunodeficiency virus 1 is localized in the third variable (V3) domain of the external envelope and has been shown to bind isolate-specific antibodies. Therefore, the extent of variation within the nucleic acid sequence encoding this epitope was studied in DNA directly obtained from peripheral blood mononuclear cells of six children and their plasma donor. This revealed that the quasi-species distribution of sequences obtained after cloning varied from recipient to recipient and that the distance from the donor sequences increased over time. V3 nucleotide evolution rates averaged 9.5 X 10-3 per site per year for silent sites and 11.4 X 10-per site per year for nonsilent sites (vs. 9.7 and 9.8 x 10-3 per site per year for a control region 5' adjacent to the V3 region) and, although individual differences were observed, did not correlate with the serum antigen levels or disease progression. Sequences of both the epitope coding region itself (V3) and the control region upstream diverted more from the donor sequence among children not progressing to AIDS than among children progressing to AIDS. The evolution of V3 sequences is apparently host dependent, rapid, and independent of the level of antigen expression.
The third hypervariable region (V3) of the human immunodeficiency virus 1 (HIV-1) envelope glycoprotein gpl20 contains a neutralization epitope that is highly antigenic (1) (2) (3) (4) . Antibodies binding to the amino acid stretch between amino acids 307 and 321 exhibit isolate-specific virus-neutralizing and cell fusion-inhibiting activities (1) (2) (3) (4) (5) (6) (7) . Moreover, Takahashi et al. (8, 9) showed that the V3 region encompasses a major histocompatibility complex class I-restricted isolatespecific determinant for cytotoxic T lymphocytes (CTLs). Although the significance of neutralizing antibodies and CTLs in the protection against HIV-related disease is not clear, recent data lend support to the in vivo importance of neutralizing antibodies. Emini et al. (10) demonstrated the protective nature of such antibodies in experimentally inoculated chimpanzees, and Girard et al. (11) reported a successfully withstood virus challenge after vaccination with a HIV-1 envelope mixture and booster injection with a peptide containing the V3 epitope. Since virus-neutralizing antibodies directed toward the V3 region are isolate specific, it is essential to determine the prevalence ofdifferent serotypes in the population in order to design rational antigen mixtures for a multivalent vaccine. Prevalence of serotypes may well differ geographically. A high percentage (87-94%) of members of different cohorts from Amsterdam had antibody reactivity against a MN/SC-like protein, in contrast to 51% of Tanzanians (12) . Devash et al. (13) recently showed that the majority of HIV-infected individuals responds immunologically to viruses antigenically related to MN. While a single amino acid change may result in profound changes in recognition by neutralizing antisera (7, 14) and a single amino acid exchange can lead to a'complete reversal of the CTL specificity directed against IIIB and MN peptides'(9), extensive heterogeneity has been described within individuals at one moment and in sequential isolates of different time points of one person (15) (16) (17) (18) (19) . To obtain insight in the variation ofthe V3 region within one individual and the effect of a divergent immune status on this variation, we had the opportunity to study six children who became infected by plasma from a single donor.
In vitro propagation of virus is likely to select for viruses best adapted to tissue culture conditions and thus may not be representative of the viral population present in the host (18) . For that reason, our sequence data were derived from DNA directly amplified from peripheral blood mononuclear cells (PBMCs) without prior cultivation.
MATERIAL AND METHODS Cells. Sequential PBMCs were taken from six children who had been infected with HIV-1 by one or more transfusions of plasma from one donation of a single donor between April and November 1981 (20) .
The clinical course of the children showed a great variability (Fig. 1) . Children 5 and 6 showed chronic disease starting in the first year of life and developed AIDS (P2B and P2C) 1.5 years and 9 months after birth, respectively. Child 6 died at 6.5 years of age. Child 3 developed AIDS (P2C) later in infection. Children 2 and 4 developed nonspecific symptoms (P2A) at a later age and up to now child 1 has remained healthy except for a mild lymphadenopathy. If available, samples of different time points varying in time after infection from 9 to 96 months were studied. The donor, whose recent status is unknown, was clinically asymptomatic upon analysis in 1985 (51 months after blood donation).
Molecular Cloning. Isolation of DNA from the PBMCs proceeded according to Boom et al. (21) . Samples of 500 ng of DNA were subjected to polymerase chain reaction (PCR) (22) . Primers used to amplify the V3 domain were J-5'-2-KSI (5'-ATAAGCTTGCAGTCTAGCAGAAGAAGA-3'; HXB2, positions 7011-7029; Los Alamos 1990) and J-3'-2-KSI-2 (5'-ATGAATTCTGGGTCCCCTCCTGAGGA-3'; HXB2, positions [7313] [7314] [7315] [7316] [7317] [7318] [7319] [7320] [7321] [7322] [7323] [7324] [7325] [7326] [7327] [7328] [7329] [7330] [7331] 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (Table 1 ). Yet, the degree of variation to the donor, which ranged from 1.0% to 8.6%, was not a mere function of time but differed from child to child. Moreover, it should be emphasized that the donor population determined in June 
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. region of 78 nucleotides with unknown function and antigenicity that is localized between the second conserved and V3 envelope region (23) . Again, in each child a unique selection of deduced consensus amino acid sequences was found (Fig.   3 ). Moreover, sequences seem to diverge continuously from the donor sequence; the same as has been found for the V3 region. As depicted in Fig. 4 , the degree of amino acid variation of this region of intermediate variability toward the donor population correlated strongly with that of the V3 region (r = 0.71; P < 0.01).
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Sequence Variation Within One Child. Comparing two sequential samples of one child drawn at least 22 months apart, we found numerous nucleotide differences between the sequences of each time point. As the differences were not proportional to the time between the isolates, nucleotide evolution rates calculated were different for each child (Table  2 ). All five children, of whom two samples were studied in each, were antigenemic (expression of HIV-1 p24 antigen in serum) in this period. Level of p24 antigenemia was highest for child 3 (up to 862 pg/ml) and lowest for child 2 (highest value, 180 pg/ml). A comparison of the evolution rate for silent versus nonsilent sites reveals that on average these differed not substantially [9. 
Distribution of Variation in the V3
Region. An examination of the variation within the coding region for the V3 epitope has shown a distinct pattern of variation distribution (Fig. 5) .
The most prominent feature of the observed variation is the low amount ofvariation at the predicted crown ofthe V3 loop (GPGRAF) such hot spots of variation were compared with the inherent variability ofthe amino acids per se (25) , the serine at position 306 and the tyrosine at position 316 were not expected to vary as much as they did (Fig. 5 ).
DISCUSSION
One of the most striking features of the multiplication of retroviruses is the number of misincorporated nucleotides in the progeny genomes. As a result of this, not a single fittest genome but rather an ensemble of mutants will survive-the so-called quasi-species. The relative representation of each mutant is determined by the rate with which it arises and the selection value against it (26, 27) . In the present investigation, we have focused on mutant frequencies within the sequences encoding the neutralizing V3 epitope in gpl20 found in six children infected by plasma transfusion from a single donation. The distribution of the variation in the V3 region could not simply be explained by a nonrandom distribution of amino acids with different potentials for mutation (25) (Fig. 5) . Functional constraints of the highly conserved central amino acids (GPGRAF) and the amino acids at the stem of the proposed loop is a plausible explanation. Amino acids around the crown of the loop varied considerably, which might also be advantageous for survival by allowing escape from immune surveillance. Whereas residues 313 (R) and 315 (F) (GPGRAFYTT) appear to be important for binding to the class I major histocompatibility complex molecule, residue 316 (Y) determined the specificity for the CTL response (9) . Variation to the donor on this site was seen in child 1 (Y -* F) and child 4 (Y -* H). Changes of the most frequently found residue 308 (H), which appeared to be important for determining the specificity of the B-cell response (12, 14) , were found in clones of the donor (H --P), children 1 and 2 (H -* N), 4 (H -* Y), and 5 (H -+ S). Replacement of the H cell in all sequenced clones was seen in children 1, 2, and 4 (Fig. 2) .
The unique build-up of a quasi-species (having a defined consensus sequence) found in each child suggests a hostdependent selection. The number of unique amino acid changes within the three children that have progressed to AIDS is lower than in the others. Moreover, sequences identical to the donor sequences were only found in the two whose clinical condition deteriorated most rapidly. So, although no difference was observed in the rate of V3 variation between progressors and nonprogressors, divergence to the inoculum virus is less in progressors. This suggests that variation is driven by immunity, which initially prevents disease progression. The final outcome depends on the ability of the host immune system to suppress the selected variants.
In accordance with Meyerhans et al. (18), we found no relation between viral heterogeneity (as expressed by the average nucleotide distance between the consensus sequence and the clonal sequences on which these consensus sequences are based) and disease development.
In equine infectious anemia virus infection, distinct antigenic variants escaping neutralizing antibodies were associated with febrile episodes and could be neutralized only by serum samples taken after the clinical episode of origin (29) . A similar antigenic drift (however, without clinical episodes) has been observed in experimentally infected chimpanzees (30) . On the other hand, unless these regions are functionally coupled, correlation between the degree of variation to the According to Graur and Li (25) , inherent amino acid variability (the probability of an amino acid to be substituted in another amino acid when a single nucleotide substitution occurs at random, considering the chemical distance between the two amino acids) is indicated as highly conserved (e) and variable (o). donor population of the V3 region and the 5' adjacent region, where no T-or B-cell epitopes are located, argues against strong selective pressure on the V3 region in late infection. If V3-specific neutralization remains not only isolate specific but also variant specific, once escape mutants resistant to neutralization have developed, no further V3-specific selection is exerted on the newly arisen mutants. An alternative explanation for a lack of late selection is conformational rearrangement of the envelope in such a way that the V3 domain is no longer accessible to antibodies (30, 31) . One exception may be child 4, in which the degree of variation of the V3 region to the donor was substantially higher than that of the 5' adjacent region and in which the rate of V3 variation between the two time points exceeded that of the 5' variation. Although limited by the number of clones studied, there seems to be a continuous change of the quasi-species distribution in each child, which diverges from the inoculum. Absence of a true latency phase of the virus infection (32) (33) (34) is in accordance with this finding. The presence of p24 antigenemia in five of the six children also pleads for a continuous virus replication during infection. Interestingly, the nucleotide evolution rate of the V3 region did not correlate with the mean p24 antigen level over the period studied.
As the inoculum has not been characterized, but most likely consisted of a heterogeneous mixture of viruses, the question remains whether this divergence partly represents a selective outgrowth of virus present within the inoculum or a complete de novo variation. The fact that many changes have been detected in more than one child argues for the first possibility. The nonsilent evolution rate of the quasi-species distribution of the V3 region averaged 11.4 x 10-3 nucleotides per site per year. This approaches the rate Li et al. (35) estimated for nonsilent substitutions in hypervariable regions in the envelope (14 x 1i-0 substitutions per site per year). The average rate of nonsilent substitutions in the V3 region is higher than the rate of silent substitutions (9.5 x 10-').
Assuming a high degree of genomes encoding viable viruses, the V3 domain allows at its hot spots a myriad of amino acids without loss of function. This apparently contrasts with the GPGRAF stretch. Amino acid mutations are to a high degree nonconservative, indicating that no compositional requirement exists for most variable amino acids or that these changes are directed to allow escape from immunity.
As Temin (36) suggested, these findings among HIV isolates may be adaptive in a single individual but do not seem to involve stable genetic evolution in the population at large. For equine infectious anemia virus, it was revealed that back-mutation of the antigenic structure occurred readily during horse passage of the virus (28) . If this is similar for HIV, this indicates that HIV is subjected to multidirectional antigenic variation but has no fixed direction of variation.
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